Literature DB >> 10348290

Late retinal complications of radiation therapy for nasal and paranasal malignancies: relationship between irradiated-dose area and severity.

A Takeda1, N Shigematsu, S Suzuki, M Fujii, T Kawata, O Kawaguchi, T Uno, H Takano, A Kubo, H Ito.   

Abstract

PURPOSE: Radiation-induced cataract, once a notorious ocular complication of radiation therapy, is no longer considered a severe complication, because visual acuity can be restored by surgical treatment without significant complications. Late retinal complications of retinopathy and glaucoma, for which there is no effective method of treatment, have become serious complications of radiotherapy of the head and neck. We retrospectively investigated the risk of late retinal complications of radiotherapy for nasal and paranasal malignancies according to the radiation dose and area of the retina irradiated. METHODS AND MATERIALS: Between October 1982 and May 1996, 43 eyes of 25 patients were exposed to fractionated external-beam irradiation for treatment of advanced nasal and paranasal cancer. None of the patients had tumor invasion into the eyes. The patients were followed ophthalmologically for a minimum of 2 years (range 2.0-11, mean 4.5, median 3.3). The radiation dose and area of the retina irradiated were estimated from the dose distribution figures calculated using the portal films and CT scan.
RESULTS: Major late adverse effects of radiotherapy were observed in the retina in 9 of 43 eyes (in 8/25 patients). Radiation retinopathy was observed in 7 eyes, and the cumulative incidence was 25%. The median interval before the onset of symptoms attributable to retinopathy was 32 months (range 16-60). Neovascular glaucoma developed in 3 of the 43 eyes, with a cumulative incidence of 7%. The median period to the onset of symptoms attributable to glaucoma was 22 months (range 16-26). Obstruction of the central retinal artery was observed in 1 eye. The irradiation doses to the retinas that developed late complications ranged between 54-75 Gy (mean 61, median 61). No patients who received less than 50 Gy developed retinal complications. The retina in 21 eyes was exposed to a dose of 50 Gy or more. In 13 of the 21 eyes, 60% or more of the retina was irradiated, and 8 of the eyes (62%) in this group (> or = 50 Gy, > or = 60%) developed severe retinal complications, whereas such complications only developed in 1 of the 8 eyes (13%) in the other group (> or = 50 Gy, > or = 60%). The results suggest that the radiation dose and area irradiated are the most important factors in the development of severe complications.
CONCLUSION: Radiation-induced retinopathy and glaucoma are more serious late complications than cataracts, which are easily treated with surgery. We investigated the risk of late retinal complications of radiotherapy, and our findings suggested that the radiation dose and area irradiated are the most important factors in the development of severe complications. We recommend that the radiation dose and area of the retina irradiated be minimized in patients at risk of eye complications, and the patients should be closely followed by periodic ophthalmologic testing after treatment.

Entities:  

Mesh:

Year:  1999        PMID: 10348290     DOI: 10.1016/s0360-3016(99)00057-7

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  20 in total

1.  Ten-year follow-up of eyes treated with stereotactic fractionated external beam radiation for neovascular age-related macular degeneration.

Authors:  Rupan Trikha; Lawrence S Morse; Robert J Zawadzki; John S Werner; Susanna S Park
Journal:  Retina       Date:  2011 Jul-Aug       Impact factor: 4.256

Review 2.  Neovascular glaucoma.

Authors:  Sohan Singh Hayreh
Journal:  Prog Retin Eye Res       Date:  2007-08-08       Impact factor: 21.198

Review 3.  Proton beam radiation therapy for head and neck malignancies.

Authors:  Steven J Frank; Ugur Selek
Journal:  Curr Oncol Rep       Date:  2010-05       Impact factor: 5.075

Review 4.  Non-Graft-versus-Host Disease Ocular Complications after Hematopoietic Cell Transplantation: Expert Review from the Late Effects and Quality of Life Working Committee of the Center for International Blood and Marrow Transplant Research and the Transplant Complications Working Party of the European Society for Blood and Marrow Transplantation.

Authors:  Yoshihiro Inamoto; Igor Petriček; Linda Burns; Saurabh Chhabra; Zachariah DeFilipp; Peiman Hematti; Alicia Rovó; Raquel Schears; Ami Shah; Vaibhav Agrawal; Aisha Ahmed; Ibrahim Ahmed; Asim Ali; Mahmoud Aljurf; Hassan Alkhateeb; Amer Beitinjaneh; Neel Bhatt; Dave Buchbinder; Michael Byrne; Natalie Callander; Kristina Fahnehjelm; Nosha Farhadfar; Robert Peter Gale; Siddhartha Ganguly; Shahrukh Hashmi; Gerhard C Hildebrandt; Erich Horn; Ann Jakubowski; Rammurti T Kamble; Jason Law; Catherine Lee; Sunita Nathan; Olaf Penack; Ravi Pingali; Pinki Prasad; Drazen Pulanic; Seth Rotz; Aditya Shreenivas; Amir Steinberg; Khalid Tabbara; André Tichelli; Baldeep Wirk; Jean Yared; Grzegorz W Basak; Minoo Battiwalla; Rafael Duarte; Bipin N Savani; Mary E D Flowers; Bronwen E Shaw; Nuria Valdés-Sanz
Journal:  Biol Blood Marrow Transplant       Date:  2018-12-03       Impact factor: 5.742

5.  Complication of an Ahmed glaucoma valve implant: tube exposure with methicillin-resistant Staphylococcus aureus infection.

Authors:  Morgan L Pansegrau; Eddie Mengarelli; Inci Irak Dersu
Journal:  Digit J Ophthalmol       Date:  2015-10-28

6.  Late onset of subfoveal choroidal neovascularisation following cerebral radiotherapy.

Authors:  Abdul-Jabbar Ghauri; Mohammed Musadiq; Ying Sha; Samer Elsherbiny
Journal:  BMJ Case Rep       Date:  2010-11-23

7.  Intravitreal bevacizumab for delayed radiation maculopathy and papillopathy after irradiation for maxillary sinus cancer.

Authors:  Miki Gondo; Tsutomu Sakai; Hiroshi Tsuneoka; Chihiro Kanehira
Journal:  Clin Ophthalmol       Date:  2011-08-30

8.  Sinonasal malignancies and charged particle radiation treatment: a systematic literature review.

Authors:  Marco Cianchetti; Maurizio Amichetti
Journal:  Int J Otolaryngol       Date:  2012-05-27

9.  Intensity modulated radiotherapy (IMRT) in patients with carcinomas of the paranasal sinuses: clinical benefit for complex shaped target volumes.

Authors:  Stephanie E Combs; Stephan Konkel; Daniela Schulz-Ertner; Marc W Münter; Jürgen Debus; Peter E Huber; Christoph Thilmann
Journal:  Radiat Oncol       Date:  2006-07-21       Impact factor: 3.481

10.  Dosimetric comparison between coplanar and non coplanar field radiotherapy for ethmoid sinus cancer.

Authors:  Antoine Serre; Katia Idri; Pascal Fenoglietto; Norbert Ailleres; Lore Santoro; Claire Lemanski; Renaud Garrel; Marc Makeieff; Ali Allaw; Jean-Bernard Dubois; David Azria
Journal:  Radiat Oncol       Date:  2007-09-18       Impact factor: 3.481

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.